Booster dose is available to all residents aged 18+ and can be applied six months after the second dose of any other vaccine administered in UAE
Applications supported by positive results from the pivotal Phase 3 POETYK-PSO clinical trial program demonstrating superior efficacy of deucravacitinib over Otezla (apremilast)
This agreement marks a milestone for Baidu to use its strengths in computational biology to optimize mRNA vaccine and therapy designs
The partnership will help advance GreenLight's messenger RNA Covid-19 vaccine candidate
The loan will fund at least 667 million Covid-19 vaccine doses for an estimated 317 million people
A first for the Asian market, addressing the health spends needs of over 200 million households.
Obseva announced previously that the company has entered into a partnership with Syneos Health to support commercialization of linzagolix in the US and EU
Premas Biotech is the developer of the technology for the Covid-19 vaccine and a shareholder in Oravax Medical
It is anticipated to be safe and efficacious by targeting the receptor-binding domain (RBD) of the new coronavirus
BRIDGE-1 Comprehensive care programme for Type 1 diabetes and to train 400 physicians and benefit over 1000 children
Subscribe To Our Newsletter & Stay Updated
